Associate Professor Rodney Baber

Clinical Associate Professor
Obstetrics, Gynaecology and Neonatology, Northern Clinical School

Telephone +61 2 9439 3058
Fax +61 2 9906 8516

Map

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Baber, R. (2014). East is east and West is west: Perspectives on the menopause in Asia and the West. Climacteric, 17(1), 23-28. [More Information]
  • Baber, R. (2014). On aspirations. Climacteric, 17(3), 213-214. [More Information]
  • Baber, R. (2014). Primary ovarian insufficiency. Medicine Today, 15(3), 73-75.
  • Shapiro, S., DeVilliers, T., Pines, A., Sturdee, D., Archer, D., Baber, R., Panay, N., Farmer, R., Stevenson, J., Mueck, A., et al (2014). RE: Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Women's Health Initiative Observational Study. Journal of the National Cancer Institute, 106(2), djt372-djt372. [More Information]
  • Shapiro, S., De Villiers, M., Pines, A., Sturdee, D., Baber, R., Panay, N., Stevenson, J., Mueck, A., BURGER, H. (2014). Risks and benefits of hormone therapy: Has medical dogma now been overturned? International Journal of Stroke, 17(3), 215-222. [More Information]
  • Cusack, L., Brennan, M., Baber, R., Boyle, F. (2013). Menopausal symptoms in breast cancer survivors: management update. British Journal of General Practice, 63(606), 51-52. [More Information]
  • Gompel, A., Baber, R., de Villiers, T., Huang, K., Santen, R., Shah, D., Villaseca, P., Shapiro, S. (2013). Oncology in midlife and beyond. Climacteric, 16(5), 522-535. [More Information]
  • de Villiers, T., Pines, A., Panay, N., Gambacciani, M., Archer, D., Baber, R., Davis, S., Gompell, A., Henderson, V., Langer, R., et al (2013). Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric, 16(3), 316-337. [More Information]
  • Baber, R. (2012). Breast cancer in postmenopausal women after hormone therapy. JAMA, 305(5), 466-467. [More Information]
  • Baber, R. (2012). Possible net harms of breast cancer screening. Climacteric, 15(4), 398-399. [More Information]
  • Archer, D., Sturdee, D., Baber, R., de Villiers, T., Pines, A., Freedman, R., Gompell, A., Hickey, M., Hunter, M., Lobo, R., et al (2011). Menopausal hot flushes and night sweats: where are we now? Climacteric, 14(5), 515-528. [More Information]
  • Sturdee, D., Pines, A., Baber, R., et al (2011). Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric, 14(3), 302-320. [More Information]
  • Baber, R. (2010). Phytoestrogens and post reproductive health. Maturitas, 66(4), 344-349. [More Information]
  • Huang, K., Baber, R. (2010). Updated clinical recommendations for the use of tibolone in Asian women. Climacteric, 13, 317-327.
  • Patching van der Sluijs, C., Bensoussan, A., Chang, S., Baber, R. (2009). A randomized placebo-controlled trial on the effectiveness of an herbal formula to alleviate menopausal vasomotor symptoms. Menopause, 16(2), 336-344. [More Information]
  • Kenemans, P., Bundred, N., Foidart, J., Kubista, E., Von Schoultz, B., Sismondi, P., Vassilopoulou-Sellin, R., Yip, C., Egberts, J., Mol-Arts, M., Baber, R., et al (2009). Safety and effi cacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. Lancet Oncology, 10, 135-146. [More Information]
  • Stuart, O., Morris, A., Baber, R. (2009). Vernix caseosa peritonitis - no longer rare or innocent: a case series. Journal of Medical Case Reports, 3, 60. [More Information]
  • Baber, R. (2007). HRT and Gynaecological Cancers. Menopausal Medicine, 14(3), S8-S12.
  • Nippita, T., Baber, R. (2007). Premature ovarian failure: a review. Climacteric, 10(1), 11-22. [More Information]
  • Nachtigall, L., Baber, R., Barentsen, R., Durand, N., Panay, N., Pitkin, J., van de Weijer, P., Wysocki, S. (2006). Complementary and Hormonal Therapy for Vasomotor Symptom Relief: A Conservative Clinical Approach. Journal of Obstetrics and Gynaecology Canada, 28(April), 279-289. [More Information]
  • Peeyananjarassri, K., Baber, R. (2005). Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials. Climacteric, 8(1), 13-23. [More Information]
  • Thewes, B., Meiser, B., Taylor, A., Phillips, K., Pendlebury, S., Capp, A., Dalley, D., Goldstein, D., Baber, R., Friedlander, M. (2005). Fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer. Journal of Clinical Oncology, 23(22), 5155-5165. [More Information]
  • Baber, R., Hickey, M., Kwik, M. (2005). Therapy for Menopausal Symptoms During and After Treatment for Breast Cancer. Safety Considerations. Drug Safety, 28(12), 1085-1100. [More Information]
  • Raja, C., Hansen, R., Baber, R., Allen, B. (2004). Hip Girth As A Predictor Of Abdominal Adiposity In Postmenopausal Women. Nutrition: an international journal of applied and basic nutritional science, 20(9), 772-777.
  • Davis, S., O'Neill, S., Eden, J., Baber, R., Ekangaki, A., Stocks, J., Thiebaud, D. (2004). Transition From Estrogen Therapy To Raloxifene In Postmenopausal Women: Effects On Treatment Satisfaction And The Endometrium-A Pilot Study. Menopause, 11(2), 167-175.
  • Hansen, R., Raja, C., Baber, R., Lieberman, D., Allen, B. (2003). Effects of 20-mg oestradiol implant therapy on bone mineral density, fat distribution and muscle mass in postmenopausal women. Acta Diabetologica, 40, S191-S195. [More Information]
  • Baber, R., O'Hara, J., Boyle, F. (2003). Hormone replacement therapy: to use or not to use? Medical Journal of Australia, 178(12), 630-633.
  • O'Neill, S., Eden, J., Baber, R., Ekangaki, A., Stocks, J., Wolthers, T., Davis, S. (2003). Transition to raloxifene with and without low-dose estrogen therapy in postmenopausal women: effects on serum lipids and fibrinogent - a pilot study. Climacteric, 6(4), 347-353.
  • Ward, M., Morris, J., Baber, R., Visva-Lingam, S. (2002). The surgical management of postpartum haemorrhage: too little too late? Obstetrics & Gynecology, , 121-125.
  • Clifton-Bligh, P., Baber, R., Fulcher, G., Nery,, M., Moreton, T. (2001). The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism. Menopause, 8, 259-265.

2014

  • Baber, R. (2014). East is east and West is west: Perspectives on the menopause in Asia and the West. Climacteric, 17(1), 23-28. [More Information]
  • Baber, R. (2014). On aspirations. Climacteric, 17(3), 213-214. [More Information]
  • Baber, R. (2014). Primary ovarian insufficiency. Medicine Today, 15(3), 73-75.
  • Shapiro, S., DeVilliers, T., Pines, A., Sturdee, D., Archer, D., Baber, R., Panay, N., Farmer, R., Stevenson, J., Mueck, A., et al (2014). RE: Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Women's Health Initiative Observational Study. Journal of the National Cancer Institute, 106(2), djt372-djt372. [More Information]
  • Shapiro, S., De Villiers, M., Pines, A., Sturdee, D., Baber, R., Panay, N., Stevenson, J., Mueck, A., BURGER, H. (2014). Risks and benefits of hormone therapy: Has medical dogma now been overturned? International Journal of Stroke, 17(3), 215-222. [More Information]

2013

  • Cusack, L., Brennan, M., Baber, R., Boyle, F. (2013). Menopausal symptoms in breast cancer survivors: management update. British Journal of General Practice, 63(606), 51-52. [More Information]
  • Gompel, A., Baber, R., de Villiers, T., Huang, K., Santen, R., Shah, D., Villaseca, P., Shapiro, S. (2013). Oncology in midlife and beyond. Climacteric, 16(5), 522-535. [More Information]
  • de Villiers, T., Pines, A., Panay, N., Gambacciani, M., Archer, D., Baber, R., Davis, S., Gompell, A., Henderson, V., Langer, R., et al (2013). Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric, 16(3), 316-337. [More Information]

2012

  • Baber, R. (2012). Breast cancer in postmenopausal women after hormone therapy. JAMA, 305(5), 466-467. [More Information]
  • Baber, R. (2012). Possible net harms of breast cancer screening. Climacteric, 15(4), 398-399. [More Information]

2011

  • Archer, D., Sturdee, D., Baber, R., de Villiers, T., Pines, A., Freedman, R., Gompell, A., Hickey, M., Hunter, M., Lobo, R., et al (2011). Menopausal hot flushes and night sweats: where are we now? Climacteric, 14(5), 515-528. [More Information]
  • Sturdee, D., Pines, A., Baber, R., et al (2011). Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric, 14(3), 302-320. [More Information]

2010

  • Baber, R. (2010). Phytoestrogens and post reproductive health. Maturitas, 66(4), 344-349. [More Information]
  • Huang, K., Baber, R. (2010). Updated clinical recommendations for the use of tibolone in Asian women. Climacteric, 13, 317-327.

2009

  • Patching van der Sluijs, C., Bensoussan, A., Chang, S., Baber, R. (2009). A randomized placebo-controlled trial on the effectiveness of an herbal formula to alleviate menopausal vasomotor symptoms. Menopause, 16(2), 336-344. [More Information]
  • Kenemans, P., Bundred, N., Foidart, J., Kubista, E., Von Schoultz, B., Sismondi, P., Vassilopoulou-Sellin, R., Yip, C., Egberts, J., Mol-Arts, M., Baber, R., et al (2009). Safety and effi cacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. Lancet Oncology, 10, 135-146. [More Information]
  • Stuart, O., Morris, A., Baber, R. (2009). Vernix caseosa peritonitis - no longer rare or innocent: a case series. Journal of Medical Case Reports, 3, 60. [More Information]

2007

  • Baber, R. (2007). HRT and Gynaecological Cancers. Menopausal Medicine, 14(3), S8-S12.
  • Nippita, T., Baber, R. (2007). Premature ovarian failure: a review. Climacteric, 10(1), 11-22. [More Information]

2006

  • Nachtigall, L., Baber, R., Barentsen, R., Durand, N., Panay, N., Pitkin, J., van de Weijer, P., Wysocki, S. (2006). Complementary and Hormonal Therapy for Vasomotor Symptom Relief: A Conservative Clinical Approach. Journal of Obstetrics and Gynaecology Canada, 28(April), 279-289. [More Information]

2005

  • Peeyananjarassri, K., Baber, R. (2005). Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials. Climacteric, 8(1), 13-23. [More Information]
  • Thewes, B., Meiser, B., Taylor, A., Phillips, K., Pendlebury, S., Capp, A., Dalley, D., Goldstein, D., Baber, R., Friedlander, M. (2005). Fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer. Journal of Clinical Oncology, 23(22), 5155-5165. [More Information]
  • Baber, R., Hickey, M., Kwik, M. (2005). Therapy for Menopausal Symptoms During and After Treatment for Breast Cancer. Safety Considerations. Drug Safety, 28(12), 1085-1100. [More Information]

2004

  • Raja, C., Hansen, R., Baber, R., Allen, B. (2004). Hip Girth As A Predictor Of Abdominal Adiposity In Postmenopausal Women. Nutrition: an international journal of applied and basic nutritional science, 20(9), 772-777.
  • Davis, S., O'Neill, S., Eden, J., Baber, R., Ekangaki, A., Stocks, J., Thiebaud, D. (2004). Transition From Estrogen Therapy To Raloxifene In Postmenopausal Women: Effects On Treatment Satisfaction And The Endometrium-A Pilot Study. Menopause, 11(2), 167-175.

2003

  • Hansen, R., Raja, C., Baber, R., Lieberman, D., Allen, B. (2003). Effects of 20-mg oestradiol implant therapy on bone mineral density, fat distribution and muscle mass in postmenopausal women. Acta Diabetologica, 40, S191-S195. [More Information]
  • Baber, R., O'Hara, J., Boyle, F. (2003). Hormone replacement therapy: to use or not to use? Medical Journal of Australia, 178(12), 630-633.
  • O'Neill, S., Eden, J., Baber, R., Ekangaki, A., Stocks, J., Wolthers, T., Davis, S. (2003). Transition to raloxifene with and without low-dose estrogen therapy in postmenopausal women: effects on serum lipids and fibrinogent - a pilot study. Climacteric, 6(4), 347-353.

2002

  • Ward, M., Morris, J., Baber, R., Visva-Lingam, S. (2002). The surgical management of postpartum haemorrhage: too little too late? Obstetrics & Gynecology, , 121-125.

2001

  • Clifton-Bligh, P., Baber, R., Fulcher, G., Nery,, M., Moreton, T. (2001). The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism. Menopause, 8, 259-265.

To update your profile click here. For support on your academic profile contact .